MarketScan			PharMetrics
	n	%	Mean (SD), days	n	%	Mean (SD), days
Abiraterone	345	49.6	193 (131)	120	39.0	150 (118)
Cabazitaxel	6	0.9	235 (170)	1	0.3	318 (NA)
Docetaxel	113	16.2	157 (132)	93	30.2	100 (105)
Enzalutamide	125	18.0	211 (122)	27	8.8	200 (98)
Mitoxantrone	1	0.1	316 (NA)	0	0.0	NA
Radium-223	7	1.0	226 (107)	3	1.0	155 (136)
Sipuleucel-T	99	14.2	139 (130)	64	20.8	121 (111)
Total new bone metastases patients	696	100.0	184 (132)	308	100.0	134 (115)

NA = not available; Q1-Q3 = quarter 1 to quarter 3; SD = standard deviation.